On 27 January 2017 the Authority communicated to the Commission its conclusion [EFSA (European Food Safety Authority), 2016. Conclusion on the peer review of the pesticide risk assessment of the active substance thiram. EFSA Journal 2017;15(7):4700 [29 pp.]. doi:10.2903/j.efsa.2017.4700.] on whether thiram can be expected to meet the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009. The Authority identified a high acute risk to consumers and to workers from application of thiram by foliar spraying. Furthermore, it identified a high risk to birds and mammals from all representative uses assessed, including as a seed treatment, even taking into account the application of higher tier refinements in the risk assessment. Residue definitions for risk assessment purposes could not be derived from the incomplete information available on metabolite M1, consequently the assessment of consumer risk through dietary intake could not be completed and maximum residue levels could not be established. Furthermore, the formation of N,N-dimethylnitrous amide (NDMA), a substance of concern given its intrinsic hazard, in drinking water when surface water and groundwater containing thiram and its metabolite DMCS is subject to water treatment processes could not be excluded by the Authority based on the available information and in addition a high risk to aquatic organisms from exposure to DMCS was concluded by the Authority based on the limited information available. Also, based on the information available the Authority could not conclude on the endocrine disrupting potential of thiram.
Recital 8, Regulation (EU) 2018/1500
Judgment of the General Court (Seventh Chamber) of 9 February 2022. Taminco BVBA and Arysta LifeScience Great Britain Ltd v European CommissDecision
Firstly, as regards the incomplete information concerning the metabolite M1, it is explained in recital 8 of the contested implementing regulation that that data gap made it impossible to establish residue definitions for the purposes of …
9 Feb 2022 · 62018TJ0740
Judgment of the Court (Eighth Chamber) of 22 June 2023. Arysta LifeScience Great Britain Ltd v European Commission.Decision
On 9 October 2018, the Commission adopted the regulation at issue, recitals 8 and 11 of which are worded as follows: ‘(8) On 27 January 2017 the Authority communicated to the Commission its conclusion on whether thiram can be expected to …
22 Jun 2023 · 62022CJ0259